MENU
THTX
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
Theratechnologies (THTX) Ownership - Who owns Theratechnologies?
Profile
Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
57.45M
P/E Ratio
N/A
Total Cash
36.03M
Projected Growth
N/A
Total Debt
59.32M
Revenue
82.57M
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash/Share
0.78
Total Debt/Equity
N/A
Revenue/Share
2.12 USD as % of share price
Fundamentals
THTX
Capitalization
57.4M
P/E Ratio
N/A
Risk (Beta)
0.56
Dividend Yield
N/A
Total Cash
36M
Total Cash/Share
0.78
Total Debt
59.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
2.12%
Revenue
82.6M
ROE
N/A
Book Value
-23.21M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-0.13
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
364M
Current Ratio
1.10
Current Revenue Per Employee
213757.28
Dividends Per Share - Security
N/A
EBITDA
7.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
79.35
Revenue To Assets
-10.07
Shares Held By Institutions
20.5M
Shares Outstanding - Current
46M
Total Liabilities
93.4M
Total Volume MTD
N/A
Value
-1
Gain YTD
-17.377
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV)
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
2015, rue Peel
Phone
+1 514 336-7800
Employees
58
Web
https://www.theratech.com